Serotonin syndrome in a child after a single dose of fluvoxamine.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 10092727.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Serotonin syndrome, a potentially fatal iatrogenic complication of psychopharmacologic therapy, is most commonly reported with combinations of serotonergic medications. Serotonin syndrome is characterized by alterations in cognition, behavior, autonomic, and central nervous system function as a result of increased postsynaptic serotonin receptor agonism. We present the first reported case of serotonin syndrome after a single dose of fluvoxamine in a pediatric patient after ingestion of a single supratherapeutic dose of fluvoxamine.
Medical subject headings
- Attention Deficit Disorder with Hyperactivity
- Emergencies
- Fluvoxamine
- Serotonin Syndrome